Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease

By Lew Mark F.   Pahwa Rajesh   Leehey Maureen   Bertoni John   Kricorian Greg    

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 741-750

Informa Healthcare

Access to resources Recommend Favorite

Lesioning the Subthalamic Nucleus in the Treatment of Parkinson’s Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 77, Iss. 1-4, 2002-10 ,pp. : 68-72

Karger

Access to resources Recommend Favorite

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain

By Rauck Richard L.   Tark Marvin   Reyes Eva   Hayes Teresa G.   Bartkowiak Anthony J.   Hassman David   Nalamachu Srinivas   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2877-2885

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain

By Nalamachu Srinivas   Hassman David   Wallace Mark S.   Dumble Sam   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 519-530

Informa Healthcare

Access to resources Recommend Favorite

Levodopa––carbidopa intestinal gel for treatment of advanced Parkinson’’s disease

By Fernandez H.H.   Odin P.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 907-919

Informa Healthcare

Access to resources Recommend Favorite